Primary study · included by 1 review

To Evaluate and Compare Platelet-rich Fibrin and Mineral Trioxide Aggregate as Direct Pulp Capping Agents in Primary Molars: A Randomized Prospective Clinical Study.

Tiwari, 2024 · Tiwari Tanu, Tyagi Parimala, Tiwari Shilpi, et al. · International journal of clinical pediatric dentistry · 2024

Included by

Outcome this study informsPooled effectEvidenceCertainty
Clinical success (absence of symptoms, abnormal responses and radiographic signs)
Platelet-rich fibrin (PRF), alone or combined with other materials vs Mineral trioxide aggregate (MTA) · 12 months
OR 1.51 [0.94, 2.43]7 studies · 392 participantsGRADE not reported
Clinical success (absence of symptoms, abnormal responses and radiographic signs)
Platelet-rich fibrin (PRF), alone or combined with other materials vs Mineral trioxide aggregate (MTA) · 12 months
OR 1.5 [0.93, 2.43]7 studies · 392 participantsLow
Clinical success (absence of symptoms, abnormal responses and radiographic signs)
Platelet-rich fibrin (PRF), alone or combined with other materials vs Mineral trioxide aggregate (MTA) · 6 months
OR 0.77 [0.44, 1.34]7 studies · 436 participantsGRADE not reported
Clinical success (absence of symptoms, abnormal responses and radiographic signs)
Platelet-rich fibrin (PRF), alone or combined with other materials vs Mineral trioxide aggregate (MTA) · 6 months
OR 0.72 [0.29, 1.78]7 studies · 436 participantsLow

1 including review in total.